Skip to main navigation Skip to search Skip to main content

Modified fractional order IMC design based drug scheduling for cancer treatment

  • Nikhil Pachauri*
  • , Jyoti Yadav
  • , Asha Rani
  • , Vijander Singh
  • *Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    Abstract

    This paper aims to improve chemotherapy drug(s) scheduling of the drug dose injected into a patient. The existing practice has been established on experiments performed during the drug development process. In general, chemotherapeutic drugs are highly toxic in nature and directly affect the probability of a patient's survival. Therefore, a modified fractional order internal model control (MFOIMC) scheme with a minimal number of design parameters is proposed for effective drug scheduling. The proposed control scheme is a combination of fractional calculus and IMC. The fractional order IMC (FOIMC) is modified by incorporating an extra control loop with a proportional transfer function. Further, IPD and IMC control techniques are also designed for comparative analysis. The dragon fly algorithm (DA) is employed to optimize the parameters of the controller. Results show that the proposed control scheme provides a continuous and precise chemotherapeutic drug dose to the patient on a daily basis. It is also shown that MFOIMC improves IAE by 34% and 32% in comparison to IMC and FOIMC, respectively, which proves its superiority over other controllers.

    Original languageEnglish
    Pages (from-to)121-137
    Number of pages17
    JournalComputers in Biology and Medicine
    Volume109
    DOIs
    Publication statusPublished - 06-2019

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    All Science Journal Classification (ASJC) codes

    • Computer Science Applications
    • Health Informatics

    Fingerprint

    Dive into the research topics of 'Modified fractional order IMC design based drug scheduling for cancer treatment'. Together they form a unique fingerprint.

    Cite this